ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,960Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 128

$1.23M Total Retail Price of All Prescriptions

Rank: 2 out of 128

458 Patients Receiving at Least One Drug in Part D
16%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

9% of this provider’s 1,111 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$112 was the average price of a prescription from this provider, compared to $123 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LAMOTRIGINE 1,083 53 10 1 11
RISPERIDONE 907 79 2 2
TRAZODONE HCL 555 74 3 1
CITALOPRAM HBR 407 87 4 4
BENZTROPINE MESYLATE 403 27 R 5 7
ABILIFY 382 54 6 3
DIVALPROEX SODIUM ER 330 12 7 17
ESCITALOPRAM OXALATE 308 48 8 12
ZOLPIDEM TARTRATE 304 15 9 14
QUETIAPINE FUMARATE 303 23 10 5
ZIPRASIDONE HCL 302 27 11 25
BUSPIRONE HCL 278 26 12 18
SERTRALINE HCL 265 73 13 6
VENLAFAXINE HCL ER 243 45 14 9
LITHIUM CARBONATE 233 40 15 20
CYMBALTA 214 0 16 8
BUPROPION HCL SR 210 31 17 23
AMITRIPTYLINE HCL 202 24 R 18 31
FLUOXETINE HCL 198 13 19 10
BUPROPION XL 190 13 20 13
SEROQUEL 189 20 21 22
HYDROXYZINE PAMOATE 161 30 R 22 27
PAROXETINE HCL 151 15 23 21
NORTRIPTYLINE HCL 129 40 24 32
MIRTAZAPINE 121 18 25 15
LEXAPRO 120 13 26 28
CARBAMAZEPINE 107 14 27 43
GABAPENTIN 99 0 28 61
GEODON 98 0 29 54
VENLAFAXINE HCL 95 15 30 60
METHYLPHENIDATE HCL 95 0 30 41
PRISTIQ ER 95 0 30 33
CLOZAPINE 79 0 33 16
OXCARBAZEPINE 79 0 33 35
PROPRANOLOL HCL 78 0 35 45
OLANZAPINE 77 0 36 19
RISPERDAL CONSTA 75 0 37 26
SEROQUEL XR 71 0 38 37
HALOPERIDOL DECANOATE 70 0 39 39
FANAPT 70 0 39 65
HALOPERIDOL 70 17 39 24
TRIHEXYPHENIDYL HCL 68 0 R 42 58
NADOLOL 66 0 43 92
AMPHETAMINE SALT COMBO 65 12 S2 44 34
LEVOTHYROXINE SODIUM 63 17 45 55
DIVALPROEX SODIUM 58 0 46 29
CHLORPROMAZINE HCL 56 12 47 44
NAMENDA 56 0 47 30
FLUPHENAZINE DECANOATE 55 0 49 67
IMIPRAMINE HCL 54 17 R 50 57
THIOTHIXENE 50 0 51 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.